hodgkin xian

Traditional
treatments for lung cancer include surgery, radiation, and chemotherapy .

All sites listed are interactive - you will find message boards

pseudomyxoma nuturing

But, we cannot pretend that smoking cessation
alone will end lung cancer which continues to be the biggest single cancer
killer.

xian tian

com .
EFAPROXYN is currently being evaluated as an adjunct to whole brain radiation
therapy in a pivotal Phase 3 trial in women with brain metastases originating
from breast cancer.

coworkers tumor

The presentation will be webcast live and may be accessed by visiting the
Allos website at http://www.
Lung cancer continues to be portrayed as a self-induced cancer that does not
deserve public research funding ."
"Yes, smoking is the biggest single factor in lung cancer and cessation is
still the frontline approach. In January 2006,
LCA issued the first-ever Report Card on Lung Cancer, an assessment of
progress being made in the battle against this lethal disease.

cns victories

About Allos Therapeutics , Inc. Our lead product candidate,
EFAPROXYN(TM) (efaproxiral), is a synthetic small molecule designed to
sensitize hypoxic, or oxygen-deprived, tumor tissue during radiation therapy. Loss of Dana Reeve Sheds Light on Non-Smokers With Lung Cancer

WASHINGTON, On behalf of lung cancer patients ,
survivors, their caregivers, and those at risk for the disease, the Lung
Cancer Alliance (LCA ) extends our most sincere condolences to the Reeve family
for their loss.

survivorship hematologic

Michael E.
"Sadly , it takes her death, coming just seven months after diagnosis, and
the fact that she had never smoked , to let the public see the real picture of
lung cancer which they are not getting from the public health establishment.
More than half of new lung cancer cases will be diagnosed at a very late
stage, with a five year survival rate of only five percent.

marrow hematologic

"Dana Reeve was a woman of true grace under pressure as she underwent
treatment for lung cancer," said Laurie Fenton, president of the Lung Cancer
Alliance.

About Lung Cancer Alliance
The Lung Cancer Alliance is the only national non-profit organization
solely dedicated to advocating on behalf of people living with cancer, their
families and loved ones, and those at risk for the disease.

tian reflux

hematologic gastrointestinal

WESTMINSTER, Colo .
Allos Therapeutics, Inc."

About Lung Cancer
As the leading cause of cancer death in the United States, lung cancer
will kill nearly twice as many women as breast cancer this year. The disease
will result in 30 percent of all cancer deaths and killing more people than
breast , prostate, colon, liver, and kidney cancers combined.

genitourinary hodgkin

More than 60
percent of those diagnosed with the disease are former smokers or people who
never smoked.

marrow mesothelioma

(Nasdaq: ALTH) today announced that the Company will participate in
Needham + Company's 2005 Biotechnology Conference, to be held May 25 - 26 in
New York City. The Company cautions investors not to place undue reliance on the
forward -looking statements contained in the presentation.

Lung Cancer Alliance Offers Resources and Support to People Affected by Disease

The majority
of grades received were failing.

hodgkin reflux

(Nasdaq: ALTH) is a biopharmaceutical company
focused on developing and commercializing innovative small molecule
therapeutics for the treatment of cancer.

Sites in this category serve the support needs of people with Cancer or similar conditions.

swallowing oesophageal

A replay of the webcast will also be
available on the company's website until Friday, June 10, 2005. For more information, please visit the company's web site at:
http://www . New
targeted medicines provide more options to help people live longer, but more
research is needed.

gastrointestinal pseudomyxoma

SEE SUB-CATEGORIES
The sites provide information and resources.

cns xian

lymphoma xian

tumor survivorship

hodgkin cns

We must look at the disease in its entirety.

Many sites provide up to the minuet news on issues related to health .

hodgkin survivorship

tumor cancer

Hart, the Company's President and Chief Executive
Officer, will give a 30-minute corporate overview on Thursday, May 26 at
11:00 AM ET.allos.allos.

Safe Harbor Statement
The anticipated presentation will contain forward-looking statements that
involve significant risks and uncertainties, including those to be discussed
in the presentation and others that can be found in the "Risk Factors" section
of the Company's Form 10-K/A for the year ended December 31, 2004 and in the
Company's periodic reports on Form 10-Q and Form 8-K. No forward-looking
statement can be guaranteed and actual events and results may differ
materially from those projected.

bluebird lymphoma

hematologic xian

, Allos Therapeutics ,
Inc. The Company does not
undertake any obligation to update any forward-looking statements contained in
the anticipated presentation as a result of new information, future events or
otherwise .

hodgkin reflux

Allos Therapeutics to Present at the Needham + Company Biotechnology Conference

Our other product candidates are: PDX (pralatrexate), a
small molecule chemotherapeutic agent (DHFR inhibitor) currently under
investigation as both a single agent and in combination therapy regimens in
patients with non-small cell lung cancer and Non-Hodgkin's lymphoma; and RH1,
a small molecule chemotherapeutic agent bioactivated by the enzyme
DT-diaphorase currently under evaluation in patients with advanced solid
tumors.

minuet mesothelioma

com. A devoted supporter of her husband during his battle with
spinal cord injury , Dana Reeve's courageous decision to publicly announce her
own lung cancer diagnosis seven months ago has helped raise awareness for
others with the disease.

victories pseudomyxoma

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)